Phase I/II Randomized Trial of Sorafenib and Bevacizumab as First-Line Therapy in Patients with Locally Advanced or Metastatic Hepatocellular Carcinoma: North Central Cancer Treatment Group trial N0745 (Alliance)
- Citation:
- Target Oncol vol 12 (2) 201-209
- Year:
- 2017
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pmc-release
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- 6
- Parents:
- 587
- Children:
- None
- Pharmas:
- Grants:
- U10 CA035267, N01 CA035431, U10 CA180821, U10 CA035448, U10 CA063848, U10 CA180790, P30 CA015083, U10 CA180882, U10 CA035431, U10 CA025224
- Corr. Author:
- Authors:
- Joleen M. Hubbard Michelle R. Mahoney William S. Loui Lewis R. Roberts Thomas C. Smyrk Zoran Gatalica Mitesh Borad Shaji Kumar Steven R. Alberts
- Networks:
- HAWAII, LAPS-MN026, METROMIN
- Study
- NCCTG-N0745
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 1/2
- Keywords:
- Article